Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00288509
Status:
COMPLETED
Last Update Posted:
2022-09-28
First Post:
2006-02-07
Brief Title:
Open-label Extension Study of AbobotulinumtoxinA Dysport for the Treatment of Cervical Dystonia
Sponsor:
Ipsen
Organization:
Ipsen
Study Overview
Official Title:
A Phase III Prospective Multicenter Open-label Extension Study to Assess the Longer Term Safety and Efficacy of Repeated Treatment of Dysport Intramuscular Injection in the Treatment of Cervical Dystonia
Status:
COMPLETED
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to assess longer term safety and effectiveness of Dysport
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-002429-29 | EUDRACT_NUMBER | None | None |